EGFR and cancer: After highlighting the ability of GBM-EVs to induce the release of EGFR and phospho-EGFR, the authors also reported similar findings in additional cancer cell lines, including A431 (epidermal), MDA-MB-231 (breast), BxPC3, PANC-1 (pancreatic), PC-3 (prostate), HCT116, DLD-1, and CaCo-2 (colon).